FRANKFURT, Jan 25 (Reuters) – AstraZeneca’s COVID-19 vaccine is not very effective for people over 65, a German coalition source told the tabloids Bild and Handelsblatt, a move that calls into question its suitability for a mass vaccination program.
German officials fear the AstraZeneca vaccine may not be approved by European Union authorities for use in those over 65, the German tabloid said in its online edition.
This marks another potential blow for AstraZeneca, which is developing its sights with the University of Oxford. He told the EU on Friday that they could not meet the agreed supply target by the end of March. (Reporting by Edward Taylor; Editing by Dan Grebler)
to request modification Contact us at Here or [email protected]